Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin visual field safety in partial seizures
NCT00351611Phase 4Completed
- Sponsor
- Viatris
- Start
- Jul 2006
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 4, randomised, double-blind trial in focal seizures comparing Lyrica Arm with Placebo Arm (2 arms). Primary endpoint: Percentage of Participants With a Decrease From Baseline in Threshold Value in Any 5 or More Points in Humphrey 24-2 Swedish Interactive Threshold Algorithm (SITA) Standard Testing at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00351611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351611.